TAGGED IN

Boards of appeal

    [GuestPost] G1/24: Tuning in! A take on the state of proceedings before oral proceedings

    Today is the day of the highly anticipated oral proceedings on G 1/24. The referral relates to a highly fundamental question of patent law, namely how the claims of a patent should be interpreted. KatFriend, Greg Corcoran, takes us through the background to the referral, details of the latest flurry of submission and suggests the key points to look out for in the hearing today. Over to Greg!  "Today, Friday 28th March, the Enlarged Board of Appeal (EBA) will hear representations from the parties to the proceedings and the European Patent Office (EPO) for the Referral G 1/24 relating to use of the description in claim interpretation, as first reported here. This Referral has received an unusually high-level of interest, not least because the decision could impact the practice of all European patent practitioners. Over thirty Amicus Briefs were received, including two late filed and two from the same party (the epi). The President filed Comments, which some may consider controversial. The Preliminary Opinion of the EBA was unusually brief, with many commentator reports having a greater word count than that of the Opinion itself. In preparation of the hearing today, here are some highlights of the proceedings so far.  Background to the case The Referral derives from an opposition to a Phillip Morris patent (EP 3076804) for a smoking article. The Opposition decision was appealed, asking the Board of Appeal if a definition in the description of the patent could be used for a broader interpretation of the claim-term "gathered" than would be known to a person skilled in the art.  The divided case law The Referring Board noted in its Interlocutory Decision, T 439/22, that split case law existed for interpreting claims in view of the description, which refer to both Arts 84 and 69 EPC.  Tuning in to G 1/24, IPKat is all ears! The first line of case law, e.g. T 223/05, advocates that Art 84 EPC, not Art 69 EPC, applies in EPO proceedings: a patent claim should essentially be read and interpreted on its own merits rather than with the aid of the description and drawings. If the claim wording is clear to a person skilled in the art in view of the common general knowledge, reference to the description is unnecessary. Exceptionally, reference to the description and drawings may be made when a claim lacks clarity. A particular meaning present only in the description (and not the claims) cannot be used to interpret an apparently broad term of a granted claim to have narrow scope. Limiting reference to the claims on their own, or with the description, if necessary, is alleged to ensure that for a person skilled in the art the claims would be clear and unambiguous (Art 84 EPC). This ensures a proprietor cannot adopt a narrower interpretation during prosecution than after grant, preventing the ‘Angora cat’ phenomenon. In the second line of case law e.g. T 1473/19, “Article 69 EPC and the Protocol are the only provisions in the EPC containing rules for the interpretation of patent claims” and the “claims must satisfy the requirements under Article 84 EPC so that they can fulfil their purpose of enabling the protection conferred by the patent to be determined under Article 69 EPC (cf. G 2/88, Reasons 2.5)”. The description is generally taken into account for claim interpretation, unlike in the first established line of case law. Although account should be taken of the description and drawings when interpreting a claim (Art 69(1) EPC), the claims have primacy for determining the extent of protection. This recognises that features cannot be read in claims that are only present in the description.  Some commentators note that the Referring Board cites the UPC Court of Appeal decision Nanostring v 10x Genomics when referring to G 2/88 and G 6/88 (which it argues applies Art 69 EPC to patentability). Nanostring is now leading UPC case on claim interpretation. Could it be that the Referring Board is suggesting that the EPO follow the UPC or at least take note of developments in UPC practice?  What lies at the heart of the split case law is how Arts 84 and 69 EPC are applied by the EPO for claim interpretation, i.e. prior to grant and opposition.  The referral questions and provisional answers Thus, the Referring Board decided that a referral was required in view of the divergence in case law to determine the relevance of cited prior art should the claim be broadened by referring to “gathered” in the description. The Referral Questions, simplified for brevity, are:  Question 1) Is Art 69 (1) EPC and the Protocol of Interpretation legal basis for claim interpretation? Question 2) Should reference be made to the description and the drawings when interpreting claims? Question 3) Can a specification be a dictionary of definitions for the patent? Amicus Briefs, The President’ Comments and Pegram’s Third Party Observations Twenty-eight amicus briefs were filed, which is an unusually high number, by parties with interests over the full range of technical fields. In response to the Referral Questions, most briefs gave positive replies to the first Question; all but one were positive in response to the second Question; and, for the third Question, most stated a definition of a claim term in the description may not be disregarded. It should be noted that over a third of the Briefs cited T 56/21 which was decided shortly before the deadline for filing the briefs. A referral about the practice of amendment of the description had been expected from this case; yet the Board of that case decided amendment of the description on allowance was inappropriate and a referral was unnecessary, as reported here.  The President of the EPO filed his Comments at the same time as the amicus briefs. His arguments differed from any of the briefs, arguing the EBA should account for the established EPO practice under Art 84 EPC of amending the description in compliance with the allowed claims prior to grant. He considers this practice as essential for ensuring consistent claim interpretation. He cites T 438/22 that affirms the practice of amendment of the description (as reported here) and which is divergent case law relative to T 56/21. The President could be asking the EBA to check the impact of its decision against the established EPO practice. Yet others interpret the President’s Comments as asking the EBA to extend the Referral Questions to encompass the practice of amending the description.  Noting the deadline for filing amicus briefs had elapsed, John B Pegram filed third party observations, arguing, if the EBA were to extend the Referral Questions in view of the President’s arguments, interested third parties should be given the right to be heard.  Preliminary Opinion  The EBA published its Preliminary Opinion on 6 February 2025, (see IPKat). Of the three Referral Questions, the EBA appears most interested in the first Question. Simplifying the provisional answers for brevity:  Provisional Answer 1: The EBA recognises the interest in uniform claim interpretation in EPO and Board of Appeal proceedings (including pre-grant) and in post-grant national court proceedings, including the UPC. The EBA identifies two sub-questions:     A. Should the principles of claim interpretation of Art 69(1) second sentence EPC and Article 1 of the Protocol be applied for claim interpretation when assessing patentability (Articles 52 to 57 EPC);      B. Are Article 69(1) EPC and Article 1 of the Protocol the legal bases for the principles referred to in question A)?  Provisional Answer 2: The EBA views the description, and figures can be used for claim interpretation.  Provisional Answer 3: This question is inadmissible. An answer is not required for the underlying case. Through his support of the practice of amendment of the description, Art 84 EPC, the President seeks uniform claim interpretation. The President is one of the parties with such an interest that the EBA acknowledges this in the introduction to its first answer. Therefore, if the EBA has decided to ignore the President’s Comments, this is not communicated in the Preliminary Opinion. The EBA may still respond to the President's arguments. Later Filings  Normally the next filing in proceedings would be the final pleadings of the parties. Yet there are three further third-party filings:  a. Further Third-Party Observations: of 13 February present the development of Art 69 EPC evidenced by the travaux préparatoires of the EPC. Art 69 EPC is inapplicable pre-grant because the article was developed exclusively for infringement post-grant, and the reference to ‘applications’ is for ‘provisional protection’ i.e. rights conferred after publication but before grant. This appears to support the Respondent’s arguments. b. The epi filed their Second Amicus Brief on 18 February 2025 in response to the President’s Comments, noting: the Referral Questions does not directly address the adaption of the description, Art 84 EPC. The epi notes Art 84 EPC does not stipulate that the description must only contain subject matter which supports the claims. Yet it considers it is not necessary to address the question of amendment of the description in order to answer the Referral Questions.  Despite taking a position inconsistent with that of the President, the epi observes that in practice there are strongly held views for and against the practice of amendment of the description.  The epi criticises a rigid application of EPO practice as advocated by the President, noting that the patent from which the Referral derived, despite having clear claims (Art 84 EPC) during assessment of patentability, demonstrates a problem can exist when interpreting claims applying Art 69 (1) EPC and the Protocol. Such interpretation might lead to an extent of protection deviating from the subject matter for which protection is sought, and which is assessed for patentability relative to the prior art.  It presents examples that demonstrate retaining the description unrelated to the claimed invention would not be detrimental to claim interpretation post-grant, but would even assist a person skilled in the art to understand the context of the invention. Retaining such non-supporting disclosure would not automatically result in a lack of clarity, because a person skilled in the art would not rely on such disclosure for claim interpretation. If such disclosure later broadened claim scope, applying Art 69(1) EPC second sentence during patentability would ensure such broader scope would need to be patentable.  The epi repeats Pegram’s arguments and argues interested third parties had not made representations about the question of amendment of the description because this question is extraneous to the Referral. Without pleadings from all sides and views, the epi takes the position that a decision in the present proceedings on the question of amendment of the description would be premature.  c. Amicus Brief of 20 February 2025 from Mewburn Ellis (Mewburn). Mewburn represented Hoffman-La Roche in the appeal T 56/21 from which a referral on amendment of the description had been expected. As explained earlier, that Board finally decided that a referral was not necessary because adaption of the description had negative consequences post grant. The President explicitly criticised this decision at para 72 and 73 of his Comments, citing T 438/22 to affirm EPO practice.  The President’s own Comments appear to undermine the argument that the EPO practice of amending the description has sure footing, by highlighting that the practice relies on one limb of divergent EPO case law. Mewburn arguably shows that T 56/21 serves not to demonstrate that a referral on the question of amendment of description is unnecessary, but that a new referral would be appropriate.  Mewburn observes that the Preliminary Opinion is silent whether the EBA will consider the question of amendment of description.  They ask that, if the EBA decides to consider the President’s question, third parties are given the opportunity to file Amicus Briefs before the EBA’s consideration of the President’s question.  Final Arguments of the Parties  The Respondent builds on earlier arguments that the Referral is inadmissible, and the first Question really relates established practice for clarity (Art 84 EPC). The Respondent proposes to reformulate the first Question to refer to the full Protocol, including Art 2 on equivalence. They reason then that Art 69 EPC may only apply post grant. T56/21 features the same argumentation that Art 69 is inapplicable in the EPO proceedings for patentability. However, the Respondent asks that the President’s request (to consider amendment of the description) is not considered in the proceedings.  The Appellant argues that Art 69 EPC applies for patentability (see G 6/88 cited in the Referral, T439/22) so that how the EPO, Courts and public interpret the claims results in the same understanding of the claimed subject matter. Art 69 EPC is the only provision of the EPC that specifically addresses claim interpretation, and this provision explicitly states that the description and drawings must be used to interpret the claims, without condition. The Appellant supports Pegram’s arguments that amendment of the description is not part of the Referral (paragraph 157), yet it positively supports amendment of the description, noting that sometimes the practice may be ‘insufficient’ (paragraph 21). Curiously, the Appellant seems not to support Pegram’s argument that third parties should be given the right to be heard if the EBA decides to consider the President’s arguments (paragraph 156). The Appellant applies the general principles of EU Administrative Procedural law (paragraphs 24 to 43) which is applicable in most but not all EPC contracting states, as a guide for the legal principles on interpretation (Art 125 EPC) to support its arguments for harmonised claim interpretation, in applying Art 69 EPC.  It observes such an approach: would increase certainty in court decisions; is enabled by the commencement of the UPC; and would result in higher quality granted patents, which is in-line with the interests of the EPO. Points to Note for the Hearing There are many points at play in these proceedings. In view of the Preliminary Opinion, it is likely that the proceedings will focus on the first Referral Question: if the principles of Art 69 (1) EPC and its Protocol are applied to claim interpretation for patentability and if these provisions provide legal basis. The parties to the proceedings and the EPO (which will also participate in the hearing today) appear to have differing views.  Some key issues appear to be:  Will the EBA decide that the principles of Art 69 EPC and its Protocol (or even as legal basis) should be applied pre-grant for claim interpretation to assess patentability in place of Art 84 EPC? Will the EBA accept the Appellant’s arguments that the EPO should harmonise its approach to claim interpretation with the UPC? This appears to be the legal issue upon which this Referral appears to turn, and it is only supported by the Appellant.   Will the Respondent’s efforts to reformulate the first Referral Question to incorporate Art 2 of the Protocol succeed? Should the EBA accept this argument, the Referral could be swiftly concluded but given the Preliminary Opinion’s acknowledgement of the interest in consistent interpretation before the EPO and the Courts, this outcome is perhaps unlikely. How will the EBA respond to the President’s argument that the decision should account for the practice of amendment of the description? The parties to the proceedings, the two late filed Amicus Briefs and Pegram in his Observations argue that the EBA should not account for this practice when answering the Referral Questions. If the EBA does consider the President’s argument, would third parties be able to file new Amicus Briefs? There is no precedent so that outcome appears unlikely and third parties appear not have attempted to add substantial arguments, as such, in response to the President’s argument; rather the two late filed amicus briefs mainly argued against the EBA considering Amendment of the Description when answering the Referral Questions. In any event, the EBA will answer the Referral Questions as is necessary to address the issues from the originating appeal: which is unrelated to amendment of the description. It will be interesting to see the EBA’s approach on this point.  Is reference to amendment of the description completely avoidable? It is unclear if the decision can avoid reference to the amendment of the description entirely because the decision is highly likely to refer to Art 84 EPC. Further the Appellant explicitly refers to EPO practice in its arguments (paragraph 21). If the EBA decides not to consider the question of amendment of the description, it will be interesting to see how it formulates its decision in view of the Appellant’s arguments without consequences for the practice of amendment of the description. Summary These and other questions will be considered by the Enlarged Board of Appeal in the hearing today at 10am CET. The hearing can be followed by livestream using the link supplied here: Oral proceedings in case G1/24 ("Heated aerosol"). The decision is expected later this year."  Related IPKat Articles BREAKING: Referral to the Enlarged Board of Appeal on claim interpretation confirmed (G1/24) - The IPKat Deletion of claim-like clauses: Board of Appeal finds legal basis for adaptation of the description from "the EPC as a whole" (T 0438/22) - The IPKat Board of Appeal back-pedals on referral in view of "unequivocal" lack of legal basis for the description amendment requirement (T 56/21) - The IPKat GuestPost: A referral broadened? To have one’s cake, to eat it...or not yet to get it (G 1/24) - The IPKat

    G 2/21 applied to software inventions (T 0687/22)

    The EPO Board of Appeal decision in T 0687/22 confirms beyond doubt the relevance of G 2/21 to software inventions. The decision in T 0687/22 links the case law from G 1/19 and G 2/21 to highlight the importance of establishing a credible technical effect of software invention. The Patentee in the case made several attempts to formulate an objective technical problem solved by the invention based on several suggested technical effects. The Board of Appeal, citing both G 2/21 and G 1/19, was not convinced that the necessary criteria for relying on these purported technical effects were met.   Disclosure of a technical effect (G 2/21) In G 2/21 the EBA found that post-filed evidence for technical effects can be used if "the skilled person, having the common general knowledge in mind, and based on the application as originally filed, would derive said effect as being encompassed by the technical teaching and embodied by the same originally disclosed invention." (Headnote II). Subsequent Board of Appeal decisions have found that, following G 2/21, it is not necessary for applications to explicitly mention the technical effect relied on for inventive step or to provide experimental evidence in support of a technical effect. The broad applicability of G 2/21 According to T 0116/18, the technical effect relied on for inventive step only needs to be "conceptually comprised by the broadest technical teaching" and recognisable as "necessarily relevant to the claimed subject-matter." T 2465/19 found that “the technical effect of an invention over the closest prior art need not be explicitly stated in the application, as long as it is derivable from the original application, in particular since the closest prior art may not have been known to the applicant when drafting it”. T 1994/22 nonetheless clarified that vague statements like providing "a quality product" are insufficient to support specific undisclosed technical effects (IPKat).  The applicability of G 2/21 to software inventions Many of the Board of Appeal decisions to apply G 2/21 have been in biotech and chemistry field, including cases relating to a second medical use (T 0258/21, IPKat),  polymorphs (T 1994/22, IPKat), and cheese (T 0629/22, IPKat). However, G 2/21 has also been applied to other fields, including semiconductors (T 2465/19, IPKat). Indeed, G 2/21 is relevant in any case for which there is a question about the disclosure of a technical effect relied on for inventive step in the application as filed (IPKat).  There is a clear connection between G 2/21 and one of the central issues for software inventions, that of establishing features of the claimed invention that contribute a technical effect. According to the established case law in the software field, a feature may be only be relied on as contributing a technical solution to the objective problem to be solved in view of the closest prior art if the features provides a technical effect (see Case Law of the Boards of Appeal, I-D-9.2.8), see also the EBA decision in G 1/19). Given the importance of identifying a technical effect for the patentability of software inventions, the guidance from G 2/21 on the disclosure and evidence requirements for technical effects relied on for inventive step is highly relevant to the field.  Establishing a technical effect of a software invention (T 0687/22) The patent at issue in T 0687/22 related to active occlusion cancellation in hearing devices (EP 3340653). T 0687/22 related to an appeal of the opposition division (OD) decision to maintain the patent in amended form. The Opponent appealed the OD decision, requesting that the patent be revoked.  The central issue in the case was whether the distinguishing features of the invention compared to the closest prior art provided a credible technical effect that solved an objective technical problem. Despite numerous attempts by the Patentee to identify a technical problem solved by the invention, including improved energy efficiency, circuit stability and flexibility, the Board of Appeal could not "identify any technical effect that can be credibly associated" with the distinguishing features (r. 2.3).  The Patentee submitted the alternative argument that the objective technical problem could be formulated as merely "providing for an alternative modification of the resulting signal based on the signal from the ear-canal microphone." However, the Board of Appeal rejected this effect for being too broad, noting that "a modification introduced solely for the sake of differentiation from the prior art simply means that, at most, the novelty requirement of Article 54 EPC is met" but does not guarantee compliance with Article 56 EPC (r. 2.3.4).  Given the absence of a credible technical effect that could be associated with the distinguishing features of the claimed invention, the Board of Appeal concluded that none of the requests were allowable under Article 56 EPC. As a result, the patent was revoked. Relevance of G 2/21 to software inventions  Interestingly, in its reasoning in T 0687/22, the Board of Appeal made a direct reference to both G 2/21 and G 1/19: [w]hen following the problem-solution approach to assess inventive step in the case in hand, a technical effect associated with the distinguishing feature(s) of the invention must be identified on the basis of the claim wording to establish a credible objective technical problem (see e.g. G 1/19, Reasons 82 and 124 as well as G 2/21, Reasons 25). If no such technical effect can be identified, there is not necessarily any technical problem to be solved (see e.g. G 1/19, Reasons 49).  In reason 25 of G 2/21, cited by the Board of Appeal, the EBA noted:  The technical problem must be derived from effects directly and causally related to the technical features of the claimed invention. An effect could not be validly used in the formulation of the technical problem if the effect required additional information not at the disposal of the skilled person even after taking into account the content of the application in question. T 0687/22 thus confirms the clear relevance of G 2/21 to software inventions, and specifically to the criteria for establishing a technical effect of the distinguishing features of the invention in the application as filed.  A possible avenue for the Patentee to rescue the case might have been to provide some post-published evidence of their purported technical effects. The Board of Appeal would then have had to assess whether the criteria of G 2/21 were met, namely whether the technical effect relied on was encompassed and embodied by the application as filed. However, no post-published evidence was submitted, and so this issue was not considered.  Final thoughts While the focus of commentary about G 2/21 has been on its relevance to biotech and chemistry cases, its principles are equally applicable to software inventions. T 0687/22 confirms the relevance of G 2/21 to software inventions, and particularly the need to both establish a credible technical effect for your invention that is identifiable from the application as filed. G 2/21 was not focused on the concept of plausibility, given that it was primarily concerned with the disclosure requirements for a technical effect relied on for inventive step. However, the focus of the decision in T 0687/22 on the credibility of the alleged effects is also a reminder that the concept of plausibility/credibility in inventive step is highly applicable to software inventions. More on this to follow!  Further reading The relevance of G 2/21 to machine learning inventions (T 2803/18) (Aug 2023)

    EBA's preliminary opinion in G1/24: "the description and the figures can be referred to in the course of claim interpretation"

    The Enlarged Board of Appeal (EBA) has issued its preliminary opinion in the closely watched referral G1/24 relating to the role of the description in claim interpretation. The preliminary opinion provides the EBA's initial view on the three referred questions ahead of oral proceedings scheduled for 28 March 2025. The EBA's thoughts on the three questions are very brief, and only Questions 1 and 2 are considered admissible.  Legal background: Claim interpretation The referral in G1/24 originated from T 0439/22 and relates to fundamental questions regarding claim interpretation at the EPO. The question at the heart of the referral in G1/24 is whether, and to what extent, the description should be taken into account when interpreting the claims. The referred questions particularly seek clarity on the relationship between Article 69(1) EPC and Article 84 EPC. Article 69(1) EPC states that "the extent of protection conferred by a European patent or a European patent application shall be determined by the claims" whilst "the description and drawings shall be used to interpret the claims". Article 84 EPC states that "the claims shall define the matter for which protection is sought" and "shall be clear and concise and be supported by the description". The Board of Appeal in T 0439/22 found disparity in the case law on how and if the provisions of Articles 69 and 84 should be applied to claim interpretation.  And then there were two Case background: G1/24 - spiralled or gathered? The referral stems from pending appeal T 0439/22  concerning Philip Morris' European patent EP3076804. The patent, which survived opposition at first instance, relates to a cartridge for a "heat-not-burn" smoking device where tobacco is heated rather than burnt. The central issue in the appeal is whether the claims lack novelty. The dispute hinges on the interpretation of the term 'gathered' in the claims, which specify that the cartridge comprises 'gathered' smoking material. The prior art discloses a cartridge comprising 'spirally wound' smoking material. The description provides an unusually broad definition of 'gathered'. The Board of Appeal noted that this definition appeared to conflict with the normally narrower meaning of the term in the tobacco industry. The Opposition Division had applied what the Board of Appeal termed the "classical approach" to claim interpretation, following the principle that the description should only be consulted to construe unclear claim terms. Under this approach, recourse to the description is prohibited when interpreting otherwise clear claim language. Nonetheless, the Board of Appeal identified a divergent line of case law, exemplified by T 1473/19, which holds that definitions provided in the description "cannot be left unconsidered". The outcome of the appeal turns on this point of claim interpretation. Considering the description's broad definition would favour the Opponent's novelty attack, whilst interpreting the claim term 'gathered' according to its normal meaning without reference to the description would support the Patentee's case for novelty.  The questions referred to the EBA are as follows:  Question 1: Application of Article 69(1) EPC during examination The first referred question asks: "Is Article 69(1), second sentence, EPC and Article 1 of the Protocol on the Interpretation of Article 69 EPC to be applied to the interpretation of patent claims when assessing the patentability of an invention under Articles 52 to 57 EPC?". In other words, Question 1 asks whether Article 69(1) EPC is relevant during pre-grant examination and opposition.  Question 2: Role of description and drawings The second question asks: "May the description and figures be consulted when interpreting the claims to assess patentability and, if so, may this be done generally or only if the person skilled in the art finds a claim to be unclear or ambiguous when read in isolation?". In other words, Question 2 asks whether the description should be used to interpret the claims, and if so, whether this should only be to resolve otherwise unclear claim language. There is a significant body of Board of Appeal case law finding that the description should only be consulted if the claim language would be unclear to a skilled person.  Question 3: Definitions in the description The third question asks: "May a definition or similar information on a term used in the claims which is explicitly given in the description be disregarded when interpreting the claims to assess patentability and, if so, under what conditions?" The EBA's preliminary opinion The EBA's initial view is that Questions 1 and 2 are admissible, whilst Question 3 is deemed inadmissible.  On Question 1, the EBA notes the interest in the "uniform application of the principles of claim interpretation both in patent grant proceedings [...] and also in post-grant revocation and infringement proceedings before the courts of the EPC contracting states, including the Unified Patent Court". So far, the UPC has taken the approach of considering the patent as a whole such that the description should always be used to interpret the claims. The EBA considers Question 1 to raise at least two issues that need addressing. First, whether the principles of Article 69 EPC and the Protocol should be applied during examination, and second, whether they provide the legal basis for the principles to be applied the interpretation of the claims.  For Question 2, regarding whether the description and figures may be consulted when interpreting claims, the EBA's preliminary view is that "the description and the figures can be referred to in the course of claim interpretation" (r. 2). The EBA's thoughts on this question are very brief and so we await the final decision for the EBA's analysis.  The EBA's preliminary view is that Question 3 is inadmissible. Again, the EBA's reasoning is very brief. The EBA merely notes that "an answer to it is not required for the referring Board to reach a decision on the case before it" (r. 3). Final thoughts The EBA in its preliminary opinion has also chosen to so-far ignore the intervention of the President of the EPO that the referral should be broadened to consider the question of description amendments (IPKat). Instead of the referral being broadened, from the preliminary opinion of the EBA, it appears that it may in fact be narrowed. However, the normal note of caution that this is only the preliminary view of the EBA applies, and we await the final decision following the March hearing.  Further reading GuestPost: A referral broadened? To have one's cake, to eat it...or not yet to get it (G 1/24) (Jan 2025) BREAKING: Referral to the Enlarged Board of Appeal on claim interpretation confirmed (G1/24) (July 2024) Will we have a referral on using the description for claim interpretation or is the Board of Appeal jumping the gun? (T 439/22) (Jan 2024) EPO tries to have its cake and eat it on claim interpretation (T 0169/20) (March 2023)

    Reliance on a silent technical effect: Application of G 2/21 to semiconductors (T 2465/19)

    The Enlarged Board of Appeal (EBA) decision in G 2/21 arose from a case seeking guidance on the evidence requirement for a purported technical effect relied on for inventive step (IPKat). However, in its final order, G 2/21 focussed less on the amount of evidence needed to support an invention, and more on the disclosure requirement for a technical effect relied on for inventive step. Therefore, while the interpretation of G 2/21 has so far predominantly been in Board of Appeal cases in the biotech field (T 0873/21, T 1394/21, T 0116/18), G 2/21 also has relevance to any case for which a new technical effect, not mentioned in the application as filed, is relied on for inventive step. The Board of Appeal in T 2465/19, for example, cited G 2/21 in a case related to the inventive step of a semiconductor.  G 2/21 case catch-up: Experimental evidence, the problem solution approach and disclosure of the technical effect Searching for semiconductors The referral in G 2/21 related to the evidence requirements for inventive step. The problem solution approach to inventive step employed by the EPO relies on identification of the "closest prior art" with respect to the claimed invention. This often creates a problem for applicants in cases where a purported technical effect requires experimental evidence. In such cases, the embodiment representing the "closest prior art" may be obscure and not known to the inventors at the filing date.  As a consequence, the applicant may fail to include data demonstrating the technical effect of the invention in view of the closest prior art in the application as filed. In such cases, the problem faced by the patentee is a need for experimental evidence that only becomes apparent after the filing date of the application. The problem of post hoc identified prior art was one of the central problem giving rise to the referral in G 2/21: "it is often necessary, like in this case, to provide post-published evidence (i.e. evidence that was not public before the filing date of the patent in suit and was filed after that date) as proof that the problem has been solved (i.e. that the alleged technical effect is actually achieved). This applies in particular when the objective technical problem has to be reformulated, e.g. with regard to a closest prior-art document previously unknown to the patent proprietor" (T 0116/18, r. 13.2) Application of G 2/21 outside of biotech There is currently some debate over the potential relevance of G 2/21 outside the setting of biotech and pharmaceutical inventions. This Kat has previously observed that G 2/21 is likely to be relevant in any field that requires evidence of a technical effect over the closest prior art (IPKat), including software and machine learning invention (T 2465/19). However, the problem of post-hoc identified prior art may even be relevant to fields for which experimental evidence is not generally required. Even for mechanical inventions, there may be circumstances where the applicant needs to rely on a technical effect for inventive step that was not mentioned in the application as filed. The application as filed may, for example, disclose all the features of the invention, but not describe the advantages of these features. The decision in T 2465/19 demonstrates that G 2/21 is also relevant to these cases.    T 2465/19: G 2/21 and semiconductors The case in T 2465/19 related to a patent application (EP2353183, Wolfspeed) for a semiconductor. The issue on appeal was inventive step. The Examining Division (ED) objected that the application as filed was silent about the technical effect of the feature distinguishing the claimed semiconductor from the prior art. For the ED, the distinguishing feature was also merely an arbitrary selection providing no advantage over the closest prior art. In response, the applicant argued that the disclosure of advantages in the description is not a requirement for inventive step, and that the claim should be construed as providing a feature that did provide an advantage.  On appeal, the Board of Appeal, citing G 2/21, agreed with the applicant that “the technical effect of an invention over the closest prior art need not be explicitly stated in the application, as long as it is derivable from the original application, in particular since the closest prior art may not have been known to the applicant when drafting it” (r. 5.3) This reasoning is in line with other interpretations of G 2/21, including T 0873/21 and T 0116/18. In T 2465/19, the Board of Appeal also construed the claimed feature differently to the ED in view of the application as whole. Following this construction, the Board of Appeal concluded that the feature was not an arbitrary selection, did in fact have an advantageous effect (r. 5.4) and provided an alternative solution on the basis of which inventive step could be acknowledged (r. 5.6). In this case, it was necessary for the applicant to demonstrate that the feature distinguishing the claimed invention from the prior art had an advantageous technical effect in view of the closest prior art. However, it was not necessary for this technical effect to be recited in the application as filed. The technical field of the invention was also such that experimental evidence of the technical effect need not be provided. As characterised by the Board of Appeal itself, the technical effect could be as straightforward as an alternative solution semiconductor that was “easier to manufacture” (r. 5.5). Final thoughts Despite being oft characterised as such, G 2/21 was not really about plausibility (IPKat). By focusing on the disclosure requirement for the technical effect, G 2/21 has become relevant to any patent wishing to rely on an advantage for inventive step that was not disclosed in the application as filed. G 2/21 also arguably did not add much, if anything, to the question of what is the appropriate standard of evidence for inventions in challenging technical fields. Unlike in the UK, the sufficiency requirement remains a low bar for a product claim (IPKat). It also remains necessary to provide some evidence (although less than might commonly be expected) in order to support a claim for a therapeutic use, in view of the higher level of doubt with regards to this type of invention (T 1394/21). Furthermore, providing enough evidence for a purported technical effect for inventive step at the EPO continues to be more challenging in certain technical fields for which there is a lot of potentially relevant prior art such as therapeutic antibodies and machine learning algorithms. G 2/21 did not change the law on any of these issues.  As interpreted by the Boards of Appeal so far, what G 2/21 did do was to clarify that a technical effect relied on for inventive step does not need to be disclosed in the application as filed (Cf. EPO Guidelines for Examination, H-V, 2.2). This point of law is relevant to any invention. In fact, with regards to disclosure requirements of a technical effect, the case law on this topic may primarily be derived from the software field, where the question is more whether any technical effect of the invention is derivable from the application as filed. We have, by this point, come a long way from "plausibility".  Further reading Plausibility demystified - a review of EPO case law before G 2/21 (Feb 2023) G 2/21: Is the technical effect embodied by the invention as originally disclosed? (March 2023) UK divergence from the EPO on plausibility (Sandoz v BMS), Part 1: Is the "plausibility" test the same for both sufficiency and inventive step? (July 2023) UK divergence from the EPO on plausibility (Sandoz v BMS), Part 2: Interpretation of G 2/21 (July 2023) Chocolate teapots and nuclear bombs: Whole range sufficiency of mechanical inventions (T 0149/21) (July 2023) The relevance of G 2/21 to machine learning inventions (T 2803/18) (Aug 2023) Interpretation of G 2/21: Inventive step may be supported solely by post-published data (T 0116/18) (Sep 2023)

Add a blog to Bloglovin’
Enter the full blog address (e.g. https://www.fashionsquad.com)
We're working on your request. This will take just a minute...